LAUSANNE: COVID-19 has presented an unprecedented global challenge, which governments and societies have met with differing degrees of success.
But with the epidemic now entering a second phase, the time has come to shift attention from single-mindedly fighting the spread of the disease to a broader debate about costs and benefits.
Devoting massive global resources to combatting COVID-19 has, like all policy choices, carried heavy opportunity costs.
During the first phase of this crisis, policymakers’ attention focused almost single-mindedly on protecting potential victims and, to some extent health care systems.
This led to a widespread confinement strategy, the cost of which was not actively debated during this first phase of the crisis.
Predictably, the relaxation of the confinement measures in many countries is leading to increases in infection rates, leading some governments to raise the prospect of re-energising a confinement policy.
I think it is time for a more nuanced and sophisticated debate about the “right” approach to dealing with this crisis.
It is hard to argue with the idea that protecting lives, particularly of the most vulnerable such as the old and chronically ill, should take precedence over everything else.
Likewise the virtually global strategy of “flattening the curve” of infections by locking down swaths of society and national economies appeared entirely rational.
THE ECONOMIC COSTS OF CONTAINING COVID-19
But our failure to discuss the collateral damage of this strategy does not make these costs go away.
First and most obvious, global economic disruption doesn’t just mean smaller dividends for shareholders and pay cuts for bosses; it also affects employers and employees.
Some governments, for example in the US, have chosen to direct significant support at employers. Others, particularly in Europe, chose to support employees.
Neither approach fully eliminates social costs while both result in huge debt being taken on by governments all over the world. This debt will be passed onto future generations and will for years reduce governments’ ability to invest in other areas.
A recent article in The Economist cited a UN study estimating that the economic impact of COVID-19 could result in the number of people suffering from intense hunger doubling to 265 million over this year.
Not only are poor countries at risk: Queues at food banks in the US have stretched across entire city blocks. "In such circumstances, even quite small dislocations in the food system could, by pushing up prices, lead to great suffering," the piece noted.
OTHER IMPLICATIONS ARE AS SERIOUS
Beyond its economic impact, the confinement strategy used in much of the world is also generating other collateral damage.
In particular, studies are already showing big rises in mental health issues as people try, and fail, to cope with crisis-caused confinement. The latter has also been the prime factor behind worldwide spikes in domestic violence.
Secondly, the global redirection of medical resources to fighting the pandemic has, inevitably, hit other patients. Tales abound of cancelled appointments and procedures.
But while delays for, say, routine surgery, like joint replacements, may be tolerable and not life threatening, what of cancelled treatments and follow ups for cancer victims?
Finally, there is the socio-economic impact on education.
Wealthier parents can compensate for school closures by providing their children with computers and private lessons. The same cannot be said for the less advantaged, whose children often lack adequate tools or support to help them keep up with their peers.
In some countries, like Singapore, efforts were taken by governments and other groups to plug this gap by providing students with personal computers so that they could continue to learn from home.
Still, these interventions were not universally adopted around the world. The result may be to set back by up to several years the hopes of such pupils to close existing socio-economic gaps.
RESOURCE ALLOCATION IS NOT EASY TO SELL
Of course, a single-minded focus in the crisis plays well politically. It is much harder to sell a nuanced strategy than one prioritising empathy for COVID patients.
Making tough choices on resource allocation would inevitably up the death toll, though the magnitude of the increase is not completely clear.
In addition, pandemic patients are in front of our eyes and their number is being monitored and communicated on a regular basis, whereas the confinement strategy’s social and economic impacts are much more diffuse and largely in the future.
But empathy can blind our judgement, prompting overinvestment in problems we can see and count at the expense of those that we cannot.
Paul Bloom, professor of psychology at Yale, has written eloquently about this danger and calls instead for “rational compassion”.
“Empathy zooms us in on the attractive, on the young, on people of the same race. It zooms us in on the one rather than the many. And so it distorts our priorities,” Bloom wrote in his 2016 book Against Empathy: The Case for Rational Compassion.
There is no doubt that the situation is complex. Much was made of Sweden’s decision to avoid following regional neighbours with strict lockdowns, prioritising instead less economically damaging approaches to slowly achieve herd immunity.
Though heavily criticised in terms of the higher mortality rate it enabled and the surprisingly low infection and immunity rate that the strategy seems to have produced, the Swedish approach sounds more sustainable over time than a heavy reliance on confinement.
Such controversies underline the fact that there is an essential discussion to be held.
Calling for an open and thoughtful debate on the risks of concentrating on a single approach to addressing COVID-19 is not a sign of insensitivity or cruelty, but a valid and rational response.
Pandemics are by no means over, and we may face a recurrence of such choices sooner than we would like. Governments need to prepare their citizens and enrol their support for the difficult decisions ahead.
Jean-François Manzoni is the President of IMD Business School in Switzerland and Singapore, where he also serves as the Nestlé Professor. His research, teaching, and consulting activities are focused on leadership, the development of high-performance organisations and corporate governance. This commentary is part of a bi-monthly CNA-IMD Business School series on leadership and business issues.